Quick Answer
Guardant Health, Inc. reported Net Income Loss of -$416.28 million for the year ending 2025.
- Guardant Health, Inc. showed an increase of +4.6% in Net Income Loss from 2024 to 2025.
- This data is from Guardant Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2016 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: -$28.59 million | Q3 2018: -$24.46 million | Q1 2022: -$123.23 million | Q2 2022: -$229.43 million | Q3 2022: -$161.99 million | Q1 2023: -$133.53 million | Q2 2023: -$72.77 million | Q3 2023: -$86.10 million | Q1 2024: -$114.99 million | Q2 2024: -$102.63 million | Q3 2024: -$107.75 million | Q1 2025: -$95.16 million | Q2 2025: -$99.90 million | Q3 2025: -$92.73 million.
- Over the full 9 years of available data (2016 to 2025), Guardant Health, Inc.'s Net Income Loss has declined by 802.2%.
- Historical annual values: Fiscal year 2025: -$416.28 million | Fiscal year 2024: -$436.37 million | Fiscal year 2023: -$479.45 million | Fiscal year 2022: -$654.59 million | Fiscal year 2021: -$384.77 million | Fiscal year 2019: -$75.65 million | Fiscal year 2018: -$85.06 million | Fiscal year 2017: -$83.22 million | Fiscal year 2016: -$46.14 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: